(Q37180389)

18 August 2017

A controlled trial of antidepressants in patients with Parkinson disease and depression (English)

1 reference

18 August 2017

0 references

1 reference

S Buyske

6

0 references

author name string

M Menza

1

1 reference

18 August 2017

R D Dobkin

2

1 reference

18 August 2017

H Marin

3

1 reference

18 August 2017

M H Mark

4

1 reference

18 August 2017

M Gara

5

1 reference

18 August 2017

K Bienfait

7

1 reference

18 August 2017

A Dicke

8

1 reference

18 August 2017

language of work or name

English

0 references

publication date

17 December 2008

1 reference

18 August 2017

1 reference

18 August 2017

72

1 reference

18 August 2017

10

1 reference

18 August 2017

886-892

1 reference

Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

The impact of depressive symptoms in early Parkinson disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Quality of life and depression in Parkinson's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Antidepressant studies in Parkinson's disease: a review and meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Inflammatory process in Parkinson's disease: role for cytokines

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

The assessment of anxiety states by rating

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Therapies for depression in Parkinson's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Short form 36 (SF36) health survey questionnaire: normative data for adults of working age

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

SSRIs in the treatment of depression in Parkinson's disease

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Factors impacting on quality of life in Parkinson's disease: results from an international survey.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

Psychometric evaluation of the Pittsburgh Sleep Quality Index.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2677475

The burden of Parkinson's disease on society, family, and the individual.

3 September 2018

1 reference

12 December 2020

A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group

1 reference

12 December 2020

Research diagnostic criteria for Parkinson's disease

1 reference

12 December 2020

Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA

1 reference

12 December 2020

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study

1 reference

12 December 2020

Paroxetine in Parkinson's disease: effects on motor and depressive symptoms

1 reference

12 December 2020

10.1212/01.WNL.0000336340.89821.B3

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference